SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Myhr Eriksson Kristina) srt2:(2015-2019)"

Sökning: WFRF:(Myhr Eriksson Kristina) > (2015-2019)

  • Resultat 1-5 av 5
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  • Machaczka, Maciej, et al. (författare)
  • Impact of imiglucerase supply shortage on clinical and laboratory parameters in norrbottnian patients with Gaucher disease type 3.
  • 2015
  • Ingår i: Archivum Immunologiae et Therapiae Experimentalis. - : Springer Science and Business Media LLC. - 0004-069X .- 1661-4917. ; 63:1, s. 65-71
  • Tidskriftsartikel (refereegranskat)abstract
    • A viral contamination of the production plant producing imiglucerase (Cerezyme™) resulted in an unpredicted worldwide shortage of global supplies during 2009-2010. The aim of the study was to describe the effects of dose reduction of enzyme replacement therapy (ERT) in adults with Norrbottnian form of Gaucher disease type 3 (N-GD3). There were ten adults with N-GD3 treated with imiglucerase in the county of Norrbotten in June 2009. Analyzed variables included plasma chitotriosidase activity and concentration of CCL18/PARC, whole blood hemoglobin concentration (Hb) and platelet count (PLT), as well as patients' body weight, subjective complaints and health status measured by the EuroQoL-5D questionnaire. The median duration of ERT shortage lasted for 14 months (10-20 months). The median percentage reduction of imiglucerase dose was 36 % (26-59 %). Hb decreased in four patients, PLT decreased in three patients, chitotriosidase increased in three patients (max. +22 % of baseline), and CCL18/PARC increased in six patients (+14 % to +57 %). The body weight was moderately decreased in one patient. No new bone events were noted. Self-assessment of individual patient's health status was stable in all but one patient. Our results suggest that moderate reduction of ERT dosage lasting for relatively short period of time can lead to worsening in biomarkers of adults with N-GD3. However, this worsening is infrequently translated to clinical worsening of patients. It is possible that CCL18/PARC has a higher sensitivity than chitotriosidase in monitoring of ERT dosing in GD3.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-5 av 5
Typ av publikation
tidskriftsartikel (5)
Typ av innehåll
refereegranskat (3)
övrigt vetenskapligt/konstnärligt (2)
Författare/redaktör
Myhr-Eriksson, Krist ... (5)
Höglund, Martin (4)
Lehmann, Sören (3)
Antunovic, Petar (3)
Möllgård, Lars (2)
Uggla, Bertil, 1962- (2)
visa fler...
Wennström, Lovisa (2)
Garelius, Hege K. G. (2)
Lazarevic, Vladimir (1)
Juliusson, Gunnar (1)
Abrahamsson, Jonas (1)
Hägglund, Hans (1)
Juliusson, G (1)
Svenningsson, Per (1)
Wåhlin, Anders (1)
Wahlin, Anders (1)
Vestergaard, Hanne (1)
Richter, Johan (1)
Porkka, Kimmo (1)
Hjorth-Hansen, Henri ... (1)
Garelius, Hege (1)
Derolf, Asa Rangert (1)
Mollgard, Lars (1)
Uggla, Bertil (1)
Lazarevic, V (1)
Stentoft, Jesper (1)
Mustjoki, Satu (1)
Stenke, Leif (1)
Dreimane, Arta (1)
Lübking, Anna (1)
Deneberg, Stefan (1)
Derolf, Åsa Rangert (1)
Strömberg, Ulla (1)
Koskenvesa, Perttu (1)
Markevarn, Berit (1)
Gedde-Dahl, Tobias (1)
Klimkowska, Monika (1)
Machaczka, Maciej (1)
Gjertsen, Bjorn (1)
Gruber, Franz X. (1)
Bjerrurn, Ole Weis (1)
Wennstrom, Lovisa (1)
Swedish AML Group, G ... (1)
Swedish Childhood Le ... (1)
Rangert-Derolf, Åsa (1)
Lazarevic, Vladimir ... (1)
Wåhlin, Anders C. E. (1)
Juliusson, Gunnar J. (1)
Kämpe Björkvall, Cec ... (1)
Wieremiejczyk, Joann ... (1)
visa färre...
Lärosäte
Uppsala universitet (5)
Karolinska Institutet (5)
Örebro universitet (2)
Linköpings universitet (2)
Umeå universitet (1)
Lunds universitet (1)
Språk
Engelska (5)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (5)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy